Drugs / LSD
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07309471 Comparator | Mar 2026 → Jul 2028 expected | — | University Hospital, Basel, Switzerland | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07309471 ↗ |
| Action | Activate | “primarily through 5-HT2A receptor agonism” NCT07309471 ↗ |
| Modality | Other / unclassified | “LSD is a classical serotonergic psychedelic” NCT07309471 ↗ |
| Route | Oral | “Single oral dose of 0.1 mg LSD.” NCT07309471 ↗ |